The Health Protection Agency (HPA) has issued a warning about the dangers of picking poisonous mushrooms.It says foragers should be aware that it is easy to mix up toxic with non-toxic varieties.Dozens of people seek medical advice each year after eating wild mushrooms which they have picked themsel

A new oral medication to treat patients in the early stages of multiple sclerosis has shown considerable promise in two clinical trials, researchers announced on Wednesday.The medication is on track to become just the third oral drug available to M.S. patients, and potentially the safest and most ef

Hundreds of thousands of pregnant women across the UK are to be offered a whooping cough vaccine to protect babies from an escalating outbreak of the disease.Very young babies are at the greatest risk of serious complications. Ten have died in the UK this year.The injection, available from Monday, s

(Reuters Health) – A study of nearly 190,000 young women injected with Merck & Co’s human papillomavirus vaccine Gardasil found no new safety concerns.Researchers said the only side effects they observed – rare cases of skin infections and fainting – were benign and expected.“This analysis was v

(Reuters) – Sanofi’s experimental pill to treat Gaucher disease, a rare inherited condition, has met its main goal in a late-stage trial, the French drugmaker said on Tuesday.Patients treated with the drug, eliglustat tartrate, showed a statistically significant improvement in the size of their sple

(Reuters Health) – For people conscious about their heart health, a new study suggests it may be best to eat fish instead of taking individual omega-3 fatty acids in supplement form.After reviewing information on the habits and fatty-acid blood levels of more than 20,000 male doctors, researchers fo

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. Scientists say they can find no co

( 11- 16 November 2013) Health Intervention and Technology Assessment Program (HITAP) researchers and the program leader, Dr. Yot Teerwattananon, made a scoping visit to Vietnam in November 2013. The purpose of the scoping visit was to evaluate the current status of Health Technology Assessment (HTA

This is the third visit of the HITAP team to the Philippines and last activity of the two vaccine evaluations project collaboration between NCPAM and HITAP with the support of Rockefeller Foundation through NICE International. The project started in March 2013 and ended in March 2014. With extensive

PMAC 2016 Side Event (SE 013): Introduction to Health Intervention and Technology Assessment: HITA 101“Health Intervention and Technology Assessment (HITA) is recognized as a tool in support of universal health coverage (UHC) to inform policy decision. It becomes an increasingly important part of pr